Skip to contentPALMISANO ROBERT J — WRIGHT MEDICAL GROUP INC insider: 144 transactions · InsiderLensPALMISANO ROBERT J
- Director at OSTEOTECH INC · on record since Jun 23, 2006
- Director at INTRALASE CORP · on record since May 2, 2006
- President & CEO at INTRALASE CORP · on record since May 2, 2006
- Director at ADVANCED MEDICAL OPTICS INC · on record since May 23, 2007
- Director at ev3 Inc. · on record since Apr 8, 2008
- President and CEO at ev3 Inc. · on record since Apr 8, 2008
- Director at WRIGHT MEDICAL GROUP INC · on record since Apr 18, 2012
- Director at AVEDRO INC · on record since Feb 19, 2019
- President and CEO at WRIGHT MEDICAL GROUP INC · on record since Sep 20, 2011
- Director at AEON Biopharma, Inc. · on record since Feb 8, 2021
- CEO at AEON Biopharma, Inc. · on record since Feb 8, 2021
- 10% owner at AEON Biopharma, Inc. · on record since Feb 8, 2021
- Director at RxSight, Inc. · on record since Aug 5, 2021
Insider trading activity of PALMISANO ROBERT J
- Transactions on record
- 144
- since Apr 28, 2005
- Open-market buys
- 1
- $997.9K
- Open-market sells
- 0
- Companies traded
- 8
- last filing Jun 22, 2026
Figures computed from official regulatory filings — methodology.
Companies where PALMISANO ROBERT J has traded
- AEON Biopharma, Inc.7 tx · Jun 22, 2026
- RxSight, Inc.7 tx · Jun 18, 2026
- WRIGHT MEDICAL GROUP INC62 tx · $39.8M · Nov 13, 2020
- AVEDRO INC15 tx · Nov 25, 2019
- OSTEOTECH INC15 tx · $97.5K · Nov 16, 2010
- ev3 Inc.16 tx · $23.4M · Jul 13, 2010
- ADVANCED MEDICAL OPTICS INC9 tx · $313.5K · Feb 27, 2009
- INTRALASE CORP13 tx · $29.7M · Apr 4, 2007
Track record of PALMISANO ROBERT J
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of PALMISANO ROBERT J
Co-insiders of PALMISANO ROBERT J
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Girin Pascal E Rev3 Inc. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 22, 2026 | Award | 222,684 | 0.00 USD | — | SEC |
| Jun 18, 2026 | Award | 37,037 | — | — | SEC |
| Jun 4, 2025 | Award | 10,752 | — | — | SEC |
| May 23, 2025 | AwardD | 308,641 | 0.00 USD | $0 | SEC |
| Sep 10, 2024 | Award | 36,021 | 0.00 USD | $0 | SEC |
| Sep 4, 2024 | AwardD | 96,210 | 0.00 USD | $0 | SEC |
| Sep 4, 2024 | Award | 36,021 | 0.00 USD | $0 | SEC |
| Jun 10, 2024 | Award | 2,554 | — | — | SEC |
| Mar 21, 2024 | AwardD | 16,260 | 0.00 USD | $0 | SEC |
| Aug 16, 2023 | AwardD | 58,851 | 0.00 USD | $0 | SEC |
| Jun 5, 2023 | Award | 5,731 | 0.00 USD | $0 | SEC |
| Jun 3, 2022 | Award | 8,624 | 0.00 USD | $0 | SEC |
| Aug 5, 2021 | Award | 5,733 | 0.00 USD | $0 | SEC |
| Aug 5, 2021 | Award | 7,645 | 0.00 USD | $0 | SEC |
| Nov 13, 2020 | OtherD | -483,849 | — | — | SEC |
| Nov 13, 2020 | OtherD | -137,373 | — | — | SEC |
| Nov 13, 2020 | Award | 229,054 | 0.00 USD | $0 | SEC |
| Nov 13, 2020 | OtherD | -129,462 | — | — | SEC |
| Nov 13, 2020 | OtherD | -145,500 | — | — | SEC |
| Nov 13, 2020 | OtherD | -144,625 | — | — | SEC |
| Nov 13, 2020 | OtherD | -181,429 | — | — | SEC |
| Nov 13, 2020 | OtherD | -239,481 | — | — | SEC |
| Nov 13, 2020 | OtherD | -9,771 | — | — | SEC |
| Nov 13, 2020 | Other | -863,885 | 30.75 USD | $26.6M | SEC |
| Nov 13, 2020 | OtherD | -598,702 | — | — | SEC |